| FioreMD vs Law | 47–42 | 52.81% |
| FioreMD vs King | 32–29 | 52.46% |
| FioreMD vs Jin | 28–32 | 46.67% |
| FioreMD vs Bryan | 26–27 | 49.06% |
| FioreMD vs Kazuya | 21–32 | 39.62% |
| FioreMD vs Steve | 27–17 | 61.36% |
| FioreMD vs Hwoarang | 22–21 | 51.16% |
| FioreMD vs Jun | 15–18 | 45.45% |
| FioreMD vs Anna | 10–21 | 32.26% |
| FioreMD vs Yoshimitsu | 15–14 | 51.72% |
| FioreMD vs Devil Jin | 12–14 | 46.15% |
| FioreMD vs Heihachi | 8–18 | 30.77% |
| FioreMD vs Xiaoyu | 15–8 | 65.22% |
| FioreMD vs Victor | 14–7 | 66.67% |
| FioreMD vs Dragunov | 11–9 | 55.00% |
| FioreMD vs Nina | 13–7 | 65.00% |
| FioreMD vs Reina | 7–13 | 35.00% |
| FioreMD vs Eddy | 10–9 | 52.63% |
| FioreMD vs Leo | 9–9 | 50.00% |
| FioreMD vs Leroy | 8–10 | 44.44% |
| FioreMD vs Paul | 6–10 | 37.50% |
| FioreMD vs Asuka | 9–7 | 56.25% |
| FioreMD vs Lili | 8–7 | 53.33% |
| FioreMD vs Alisa | 5–9 | 35.71% |
| FioreMD vs Azucena | 9–4 | 69.23% |
| FioreMD vs Clive | 5–8 | 38.46% |
| FioreMD vs Feng | 4–8 | 33.33% |
| FioreMD vs Lee | 2–7 | 22.22% |
| FioreMD vs Lidia | 3–6 | 33.33% |
| FioreMD vs Raven | 6–2 | 75.00% |
| FioreMD vs Lars | 6–1 | 85.71% |
| FioreMD vs Shaheen | 6–1 | 85.71% |
| FioreMD vs Jack-8 | 3–2 | 60.00% |
| FioreMD vs Kuma | 4–1 | 80.00% |
| FioreMD vs Zafina | 1–3 | 25.00% |
| FioreMD vs Claudio | 2–0 | 100.00% |
| FioreMD vs Panda | 0–2 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.